Aminophylline Injection, Solution
Product Images NDC 51662-1341

Product Visual Gallery

This gallery contains 15 technical images submitted to the FDA as part of the official labeling for Aminophylline (NDC 51662-1341). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Vial Label -16 (0409 5922 16 Aminophylline Vial Label)

Aminophylline Injection, USP 500 mg per 20 mL (25 mg/mL) intravenous injection, single-dose vial label. The label states protection from light and warns not to use if crystals have separated from the solution. It includes dosing information per mL, distribution by Hospira Inc., and barcode with NDC 0409-5922-16.*

FDA Label Image

Pouch Labeling (51662134122 Aminophylline Pouch Label)

Label for AMINOPHYLLINE injection USP 500 mg/20 mL (25 mg/mL) in a 20 mL vial. The label shows the NDC number 51662-1341-2, lot number 12345, and expiration date 2001-03-01. It includes manufacturer information: HF Acquisition Co., LLC, Mukilteo, WA 98275. The label indicates this product is for intravenous use and prescription only.*

FDA Label Image

Case Labeling (51662134139 Aminophylline Case Label)

Label for AMINOPHYLLINE injection, USP 500 mg/20 mL (25 mg/mL) in a 20 mL vial, packaged as a box of 25. The NDC is 51662-1341-3. Manufactured by HF Acquisition Co., LLC in Mukilteo, WA. The label includes lot number 12345 and expiration date 2030-01-01, with storage and usage instructions visible.*

FDA Label Image

Rfid Labeling (51662134139 Aminophylline Rfid Label)

A close-up image of a serialization label on AMINOPHYLLINE injection, solution 25 mg/mL. The label includes GS1 barcode data elements with identifiers such as (01) 00351662134139 and (17) 300101, along with a 2D barcode. Text indicates distribution by HF Acquisition Co LLC, Mukilteo, WA 98275, and advises consulting the manufacturer's package insert.*

FDA Label Image

Adverse (Adverse)

Data table presenting signs and symptoms observed in acute overdose (large single ingestion) and chronic overdosage (multiple excessive doses) of aminophylline, from four studies. Categories include gastrointestinal, metabolic/other, cardiovascular, and neurologic symptoms, with numeric values indicating incidence percentages or counts, and some data marked as not reported (NR).*

FDA Label Image

C1 (Clinical Pharma)

A data table showing pharmacokinetic parameters for aminophylline across various population characteristics. It lists age groups from premature neonates to elderly, and conditions such as acute pulmonary edema, COPD, cystic fibrosis, liver disease, pregnancy, sepsis, and thyroid disease. The table presents total body clearance (mL/kg/min) and half-life (hours) with mean and range values for each group or condition.*

FDA Label Image

D1 (Dosage And Administration 1)

A data table showing theophylline infusion rates (mg/kg/hr) by patient population and age groups, ranging from neonates to patients with cardiac decompensation. The table includes specific dosing rates for neonates, infants, children, adolescents, adults, elderly, and those with organ dysfunction, with values varying by age and smoking status.*

FDA Label Image

D2 (Dosage And Administration 2)

A dosage adjustment table for Aminophylline injection solution, detailing adjustments based on peak serum concentration levels ranging from below 9.9 mcg/mL to above 30 mcg/mL. The table provides specific guidance on infusion rate changes, monitoring intervals, and overdose treatment considerations.*

FDA Label Image

How Supplied (How Supplied)

A table presenting units of sale and total strength/volume (concentration) for a pharmaceutical product. It lists two NDC codes with respective packaging details: 25 units per carton at 250 mg/10 mL (25 mg/mL) and 25 units per carton at 500 mg/20 mL (25 mg/mL) concentration.*

FDA Label Image

Logo (Logo)

FDA Label Image

P1 (Precautions 1)

A data table detailing drug interactions with aminophylline, listing various drugs, their type of interaction, and the effect on theophylline concentration or clinical effects. It includes drugs like adenosine, alcohol, allopurinol, diazepam, erythromycin, and many others, describing increases or decreases in theophylline clearance, concentration changes, synergistic effects, and potential clinical outcomes such as increased sedation or risk of arrhythmias.*

FDA Label Image

P2 (Precautions 2)

This image shows a text panel listing various medications and substances including albuterol, amoxicillin, atenolol, azithromycin, caffeine, diltiazem, prednisone, and more. It appears to be part of a larger document, possibly detailing drug interactions or related information, but no specific information about Aminophylline injection is visible.*

FDA Label Image

Serialized Label (Serialized Label)

A clear glass vial of AMINOPHYLLINE injection solution, USP, 500 mg (25 mg/mL), in a 20 mL single-dose vial. The vial has a blue flip-off cap and label showing product name, strength, and manufacturer details. The label includes a barcode and a reference to the manufacturer and distributed by HF Acquisition Co., LLC, Mukilteo, WA.*

FDA Label Image

Structure (Structure)

Chemical structure of aminophylline showing its molecular composition including methyl groups, oxygen atoms, nitrogen atoms, and associated water molecules as part of the compound's chemical formula.*

FDA Label Image

Vial Label (Vial Label)

Label for AMINOPHYLLINE injection, USP, 500 mg (25 mg/mL) in a 20 mL single-dose vial. The label includes instructions to protect from light and warnings about crystal separation. Manufactured by Hospira, Inc., Lake Forest, IL, with a barcode and detailed ingredient and pH information. The product is for intravenous use only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.